BMY•benzinga•
Atlantic Equities Maintains Overweight on Bristol-Myers Squibb, Raises Price Target to $87
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 12, 2022 by benzinga